Introduction
One of the hallmarks of cancer is the accumulation of genomic abnormalities. Aneuploidy is the most frequently identified genomic abnormality in cancer and has been shown to occur early in progression, often observed in premalignant lesions. Aneuploidy is also seen in histologically normal tissue adjacent to cancer, strongly suggesting that increased dosage of oncogenic genes and decreased dosage of tumor suppressor genes may be involved in the earliest stages of tumorigenesis [1] [2] [3] [4] [5] . The mechanism by which aneuploidy is generated in the earliest stages of tumorigenesis is poorly understood. In his famous Zur Frage der Entstehung maligner Tumoren (The Origin of Malignant Tumors), published in 1914, Theodor Boveri hypothesized that multipolar mitoses cause aneuploidy [6, 7] . Events resulting in supernumerary centrosomes (more than two functional microtubule nucleating bodies) can lead to multipolar spindles and, as proposed by Boveri, lead to improper segregation of the sister chromatids and generate aneuploid daughter cells. The recent discovery of supernumerary centrosomes in premalignant and malignant lesions of the breast and their correlation with aneuploidy has provided support for Boveri's hypothesis [8] [9] [10] [11] . However, it is still unclear whether supernumerary centrosomes drive aneuploidy or simply reflect preceding consequences of aneuploidy [12] .
During the normal cell cycle of mammalian cells, the centrosome is duplicated once and only once to ensure that during mitosis each daughter cell inherits one mature centrosome containing two centrioles [13] . The centrosome duplication cycle is initiated late in the G1 phase of the cell cycle. During S phase, the first physical manifestation of centrosome duplication is splitting of one centrosome into two immature centrosomes, each containing one centriole. Synthesis of the new daughter centrioles continues through S phase, using the mother centriole as a template. Beginning in early mitosis, the centrosomes migrate to opposite poles of the cell to establish the bipolar spindle, which is critical for segregation of the duplicated DNA (sister chromatids). While cyclin-dependent kinase 2 (Cdk2) activity has been shown to be required for initiation of centrosome duplication [14] [15] [16] [17] , the molecular pathways that ensure that centrosomes are duplicated once and only once within the normal cell cycle are not well understood. Coupling of the centrosome duplication and DNA replication cycles is crucial for preventing multiple rounds of centrosome duplication within a single DNA replication cycle. Uncoupling of these two cycles is one mechanism by which generation of supernumerary centrosomes may arise [18] [19] [20] . For example, in the event that the DNA replication cycle was stalled (e.g., for DNA repair), lack of inhibition of the centrosome duplication cycle may allow for the accumulation of more than two centrosomes.
In this report, we use primary cultures of human mammary epithelial cells (HMECs) to investigate the mechanism by which cells acquire supernumerary centrosomes. Further, we determine that the acquisition of supernumerary centrosomes in genomically intact cells results in aneuploid daughter cells.
Results

Variant HMECs Accumulate Abnormal Centrosomes with Continued Population Doublings
HMECs comprise the majority of cells that expand in culture from mammary tissues obtained from healthy women [21] . When grown in vitro under standard conditions, these cells proliferate for a limited time (five to 20 population doublings [PD] ) before reaching a proliferation barrier termed selection (Figure 1) . A small subpopulation of variant cells (vHMECs) has the ability to proliferate an additional 20 to 70 PDs beyond selection ( Figure 1A ), upon which they enter a phase termed agonesence, where they accumulate genomic abnormalities, including aneuploidy, polyploidy, structural changes (deletions/translocations) and telomeric associations [22] . These genomically unstable vHMECs also contain abnormal mitotic metaphases, such as tripolar mitoses ( Figure 1B) , suggesting that the genomic instability seen in vHMECs is, in part, due to centrosome abnormalities.
To determine if centrosome abnormalities are present in vHMECs, we examined the centrosomes of these cells using an antibody that recognized c-tubulin, a component of pericentriolar material, and an antibody that recognized centrin, a component of centrioles ( Figure 1F , inset) [23] . We focused on the study of mononucleated cells with more than two centrosomes to identify events that generate more than two centrosomes in genomically intact diploid cells. Mononucleated cells from two different reduction mammoplasties (RM9 and RM16) were analyzed to control for interindividual variations. HMECs were analyzed prior to the proliferation barrier, and vHMECs were analyzed early and late along their respective growth curves as indicated by the line graph ( Figure 1A) , which represents the growth curve of cells isolated from a single reduction mammoplasty (RM16). The incidence of HMECs with more than two centrosomes is negligible (average of 1%) ( Figure 1A, 1C, and 1E) . Similarly, the average fraction of early-passage vHMECs with more than two centrosomes was not statistically different (p ¼ 0.07) than that seen in HMECs ( Figure 1A) . As illustrated by the standard deviation seen in early-passage vHMECs ( Figure 1A) , there are minor differences between individuals in the fraction of mononucleated cells with more than two centrosomes (ranging from 1% to 5%). In contrast, mononucleated vHMECs analyzed at late passage and agonescence contained an average of 10% and 32% of cells with more than two centrosomes, respectively ( Figure 1A , 1D, and 1F), which correlated with the increase in genomic instability seen in late-passage and agonescent vHMECs [22] .
To validate that the mononucleated vHMECs with more than two centrosomes at agonescence are not of polyploid DNA content, we directly determined the DNA content of each cell containing more than two centrosomes. We performed quantitative fluorescence on cells stained with propidium iodide (PI) (DNA content) and an antibody that recognized ctubulin (centrosome number). As shown in Figure 1G , the majority (94%) of the mononucleated vHMECs with more than two centrosomes had a diploid DNA content, demonstrating that mononucleated vHMECs with more than two centrosomes are not generated as a result of polyploidization.
vHMECs Acquire Supernumerary Centrosomes following Inhibition of DNA Synthesis
One mechanism by which excessive duplication of centrosomes can arise is due to uncoupling of the centrosome duplication and DNA replication cycles. To investigate if these two cycles are coupled in HMECs and vHMECs, we exposed the cells to a transient inhibition of DNA synthesis as previously described [17, 24, 25] . Exposure to hydroxyurea (HU), a reversible inhibitor of DNA synthesis, allows the cells to transition into S phase of the cell cycle but prevents them from progressing through S phase ( Figure 2 ). In cells with coupled centrosome duplication and DNA replication cycles, centrosome duplication (generating two centrosomes) occurs; however, centrosome reduplication or generation of supernumerary centrosomes (generating more than two centrosomes) is prevented.
HMECs and vHMECs from RM9 and RM16 were exposed to 4 mM HU for 48 h and were subsequently analyzed by immunocytochemistry with anti-c-tubulin antibody for centrosome number. Exposure of HMECs to HU arrested DNA synthesis but resulted in no statistically significant (p ¼ 0.60) increase in the fraction of mononucleated cells with more than two centrosomes compared to the untreated HMEC population ( Figure 2B , black bars, and 2C). In contrast, earlypassage vHMECs exposed to HU had a dramatic increase in cells with more than two centrosomes. Untreated earlypassage vHMECs contained a negligible background of cells with more than two centrosomes (ÀHU: average of 2%), whereas these same cells exposed to HU generated a striking increase in mononucleated cells with more than two centrosomes (þHU: RM9 and RM16, 18% and 22%, respectively; Figure 2B , red bars, and 2E). While the majority of the HU-exposed vHMECs with more than two centrosomes contained three or four centrosomes, a small fraction (2%) containing more than four centrosomes were also observed ( Figure 2E, closed arrowhead) . Analysis of the number of centrosomes following exposure to HU for longer periods of time (72, 96 , and 144 h) demonstrated no statistically significant increase (p ¼ 0.62, p ¼ 0.729, and p ¼ 1.00, respectively) in the fraction of vHMECs with more than two centrosomes as compared to vHMECs exposed to HU for 48 h. Longer exposure to HU also did not result in an increase in the fraction of cells (average of 2%) containing more than four centrosomes.
Two additional experiments assured us that the mononucleated cells with more than two centrosomes did not represent a polyploid population. vHMECs were sorted by flow cytometry for low forward scatter and side scatter (low FSC/SSC) and were analyzed for DNA content by staining with PI. PI staining demonstrated that the low FSC/SSC sorted population is enriched for cells containing a 2N DNA content and contains a reduced polyploid population, ranging from 0.6% to 1.5%. Treatment of low FSC/SSC vHMEC population (RM16) for 48 h with HU resulted in an average of 12% of the mononucleated cells with more than two centrosomes ( Figure  2B , blue bars). This represented a statistically significant (p , 0.005) increase over the average 0.4% observed in the untreated, low FSC/SSC sorted population.
In the second experiment, we performed quantitative fluorescence analysis to directly determine the DNA content of each individual HU-exposed, early-passage vHMEC as described above. As shown in Figure 2F ,100% of the mononucleated, HU-exposed early-passage vHMECs with more than two centrosomes had a diploid DNA content. Taken together, these results demonstrate that the generation of more than two centrosomes following inhibition of DNA synthesis is not a result of polyploidization.
Loss of p16 INK4a Plays a Causal Role in Centrosome Dysfunction in HMECs
Little is known about the mechanisms that prevent acquisition of more than two centrosomes. A distinguishing characteristic of vHMECs is loss of p16I
NK4a expression due to promoter hypermethylation [26] [27] [28] , which, as described here, is correlated with the ability to acquire centrosomal abnormalities in vHMEC. Furthermore, p16INK4a is known to be an upstream regulator of Cdk2 activity, which is required to initiate both centrosome duplication and DNA replication [14] [15] [16] [17] 29] , making it a plausible candidate for control of centrosome regulation.
To assess the role of p16 INK4a in centrosome regulation, we inhibited its expression in HMECs and exposed these cells to HU as described earlier. The p16
INK4a gene was inhibited through expression of a short hairpin RNA (shRNA) complementary to p16
INK4a [30] . Western blot analysis and immunocytochemistry demonstrated approximately 50% suppression of p16
INK4a protein expression in HMECs ( Figure  3A ). Following HU exposure, an average of 15% of earlypassage p16
INK4a -suppressed HMECs had more than two centrosomes ( Figure 3B ; Figure 3C , gray bars). This increased value was statistically significant compared to untreated cells (p , 0.005). Similar to parental HMECs, the vector-only and vector containing an shRNA to green fluorescent protein (GFP) control populations contained no statistically significant (p ¼ 0.74 and p ¼ 1.00) increase in mononucleated cells with more than two centrosomes when exposed to HU under identical conditions ( Figure 3C , black bars).
Wild-type p16 INK4a was reexpressed in vHMECs to determine if it can rescue the described centrosome dysfunction. vHMECs were transfected with p16
INK4a and then exposed to HU 8 h after transfection. Expression levels of exogenous p16
INK4a in both the presence or absence of HU were similar to physiologic levels seen in HMECs ( Figure 3D ). Cell cycle analysis demonstrated that expression of p16
INK4a under these conditions did not alter cell cycle progression as compared to vector control (data not shown). Cells were coimmunostained with antibodies to detect p16
INK4a and ctubulin. HU exposure of p16
INK4a -positive vHMEC arrested them in S phase but resulted in no statistically significant (p ¼ 0.823) increase in the fraction of mononucleated cells with more than two centrosomes as compared to the untreated p16 INK4a -positive vHMEC population ( Figure 3E ).
p16 INK4a Prevents Centriole Pair Splitting during S Phase Arrest
Loss of p16
INK4a activity in genomically intact diploid human cells following a transient S phase arrest generates three or four centrosomes. The rare observance of more than four centrosomes suggested that loss of p16
INK4a activity does not permit uncontrolled centrosome duplication under these conditions. This difference prompted us to more closely examine the supernumerary centrosomes of the vHMECs during S phase arrest. Early-passage vHMECs expressing the centriolar protein enhanced GFP (EGFP)-human centrin 2 (CETN2) were exposed to HU for 48 h and subsequently analyzed by immunocytochemistry with an antibody that recognizes the c-tubulin protein to determine centriole number per centrosome. As described above, analysis of ctubulin staining demonstrated that the vHMECs (EGFP-CETN2) exposed to HU resulted in an increase in the fraction of mononucleated cells with more than two centrosomes as compared to the untreated vHMECs (EGFP-CETN2) population ( Figure 4A and 4B). Analysis of the centriole number in each of the supernumerary centrosomes demonstrated that a statistically significant (p , 0.01) fraction of the supernumerary centrosomes contained only one centriole ( Figure 4A and 4B).
Early-passage vHMECs (EGFP-CETN2) were exposed to HU for 48 h and were subsequently released from HU exposure and allowed to reenter the cell cycle for 7 to 8 d. The vHMEC (EGFP-CENT2) HU-exposed and released cells were analyzed by immunocytochemistry with an antibody that recognizes the c-tubulin protein to determine if the pericentriolar bodies containing a single centriole could nucleate multipolar spindles. Results demonstrate that the described pericentriolar bodies containing only one centriole are able to act as functional centrosomes and nucleate microtubules during mitosis ( Figure 4C ). Therefore, for the purposes of this manuscript, these pericentriolar bodies that each contain only one centriole are referred to as supernumerary centrosomes.
Acquisition of Supernumerary Centrosomes Due to Loss of p16 INK4a Activity Correlates with the Production of Aneuploid Daughter Cells
To test if supernumerary centrosomes drive genomic instability in vHMECs, we generated more than two centrosomes in early-passage vHMECs by transient exposure to HU. Removal of the HU released the cells from inhibition of the DNA replication cycle and allowed the cells to resume cell cycle progression ( Figure 5A , bottom). HU-exposed and released HMECs and vHMECs resumed cell cycle progression similar to untreated HMECs and vHMECs ( Figure 5A ). Notably, exposure to HU did not result in an increased fraction of cells with polyploid DNA content. To test if HUexposed and released early-passage vHMECs progress through mitosis with multipolar spindles, we immunostained microtubules with an antibody that recognizes c-tubulin. Early-passage vHMECs exposed to and subsequently released from HU contained an average of 11% mitotic cells with more than two microtubule nucleation sites ( Figure 5B and 5C, red bars). This was a statistically significant increase (p ¼ 0.01) compared to that of untreated vHMECs. HMECs exposed to and subsequently released from HU did not have a statistically significant increase (p ¼ 1.00) in the fraction of multipolar mitosis compared to untreated HMECs ( Figure  5C , black bars). To determine if HU-exposed and subsequently released early-passage vHMECs have acquired genomic abnormalities, their karyotypes were analyzed and an average of 21% were found to have genomic abnormalities ( Figure 5D , red bars). Specifically, we observed that 19% of these had gained or lost one or two chromosomes (aneu- ploidy) (19 of 100 metaphases) and the remaining 2% included a structural abnormality (one of 100 metaphases) and a telomeric association (one of 100 metaphases). In contrast, early-passage vHMEC populations not exposed to HU contained only 2% metaphases with genomic abnormalities. Thus, the fraction of HU-exposed and subsequently released vHMECs with genomic abnormalities was statistically significant (p , 0.005) compared to untreated vHMECs. Notably, cells observed to have genomic abnormalities contained a near diploid, but not polyploidy, DNA content (chromosome number between 44 and 48). This further supports our conclusion that, in these cell populations, more than two centrosomes are generated in a genomically intact diploid cell rather than by polyploidization.
To control for the nonspecific effects of HU on generating aneuploidy, we also performed the described HU exposure and release on HMECs. Because HMECs did not generate a significant number of cells with more than two centrosomes during HU treatment, any increase in genomic abnormalities after their release from inhibition of DNA replication would be due to nonspecific effects of HU exposure. HMECs exposed to and released from HU demonstrated a transient inhibition of DNA synthesis ( Figure 5A , top) similar to that obtained in vHMECs under identical conditions ( Figure 5A , bottom). However, in HU-exposed and subsequently released HMECs, less than 3% of the cells contained more than two centrosomes, and no significant increase (p ¼ 1.00) in the number of metaphases with genomic abnormalities were detected ( Figure 5D , black bars). These results strongly support the conclusion that the increase in aneuploidy seen in vHMECs following transient inhibition of DNA synthesis is due to supernumerary centrosomes. We also performed the described HU exposure and release on HMECs with p16
INK4a shRNA. HU-exposed and subsequently released parental HMECs had no significant increase in the fraction of cells with more than two centrosomes and no significant increase in the number of genomic abnormalities (average of 3%, p ¼ 1.00) as compared to untreated controls ( Figure 5D , gray bars). In contrast, HMECs infected with p16
INK4a shRNA that were exposed and subsequently released from HU had a significant increase in both the fraction of cells with more than two centrosomes and aneuploidy (average of 31%, p , 0.005) following exposure to HU compared to untreated cells ( Figure 5D , gray bars).
Supernumerary Centrosomes Lead to the Production of Aneuploid Daughter Cells
While these data described above strongly suggest that supernumerary centrosomes play a causal role in genomic instability, they still represent a correlation between supernumerary centrosomes and aneuploidy. If supernumerary centrosomes play a causal role in the generation of aneuploid daughter cells, we predict that time-lapse microscopy of cells with more than two centrosomes will lead to aneuploidy following mitosis. Early-passage vHMECs were stably infected with EGFP-c-tubulin (centrosome marker) and EGFP-H2B (a quantifiable marker of DNA [31, 32] ) (vHMEC/EGFP; Figure  6A ). EGFP was used as the fluorescent marker for both of these two proteins because they localize to distinct cellular organelles, and this enabled us to image the two fusion proteins with the same laser to minimize photobleaching and phototoxicity. Expression of EGFP-c-tubulin and EGFP-H2B in the vHMECs INK4a shRNA (gray) for genomic abnormalities in untreated (ÀHU) or exposed to HU followed by release from HU treatment (þHU ! release). Types of chromosomal abnormalities represented include aneuploidy, structural abnormalities, and telomeric associations. Analysis included at least 100 metaphases. *Statistical significance (p , 0.005) based on comparison of ÀHU and þHU ! release experiments. DOI: 10.1371/journal.pbio.0040051.g005 Figure 6 . Supernumerary Centrosomes Play a Causal Role in the Production of Aneuploid Cells (A) Early-passage vHMECs (RM18, 13-33 PD) that express EGFP-c-tubulin (green) and EGFP-H2B (green) were stained with antibody recognizing the centrosome associated c-tubulin protein (red) and with DAPI to localize DNA (blue). The merged image demonstrates colocalization of EGFP-c-tubulin with the centrosome and EGFP-H2B with the DNA. (B) Examples of the mitotic progression of cells that divide into two nuclei with two centrosomes (ÀHU and þHU ! release; bipolar, two centrosomes), that divide into two nuclei with more than two centrosomes (þHU ! release; bipolar, more than two centrosomes), and that divide into greater than two nuclei with more than two centrosomes (þHU ! release; multipolar, with more than two centrosomes). Arrowhead points to the EGFP-c-tubulin signal (centrosomes). The EGFP-H2B signal was selected (pastel-colored nuclei) and the total signal intensity was quantitated. Determining the fold difference (EGFP-H2B signal intensity of daughter cells 1/EGFP-H2B signal intensity of daughter cells 2) allowed us to determine whether cells had segregated their DNA equally (fold difference close to 1.00) or unequally (fold difference .1.00). (C) Bar graph of the individual (white, black, red, and red stripe) and mean (yellow) fold differences in EGFP-H2B signals intensity between daughter cells. Standard deviations represent analysis of up to ten time frames per mitotic event. The dashed line represents the average mean fold difference (1.08) of the normal mitosis (ÀHU and þHU ! release; bipolar, two centrosomes). *Statistical significance (p , 0.05) based on comparison of the mean fold difference (yellow bars) of cells completing mitosis with two centrosomes (ÀHU and þHU ! release; bipolar, two centrosomes) compared to the individual and mean fold differences of cells completing mitosis with more than two centrosomes (þHU ! release; bipolar or multipolar, more than two centrosomes). DOI: 10.1371/journal.pbio.0040051.g006
did not alter the length of the cell cycle or the length of mitosis as compared to uninfected vHMECs or vHMECs infected with control vectors (data not shown). We generated more than two centrosomes in early-passage vHMECs expressing the EGFP fusion proteins by transient exposure to HU. The cells were released from HU, and the EGFP-H2B signal was quantified in daughter cells following mitosis.
In the control population of early-passage vHMECs expressing the EGFP fusion proteins (ÀHU), cells that entered mitosis with two centrosomes produced a bipolar mitotic division resulting in two daughter cells, with each having one nucleus and one centrosome ( Figure 6B, first row) . Analysis of the DNA content (EGFP-c-tubulin signal intensity) of each daughter cell demonstrated a mean fold difference of 1.08. Cells exposed to and subsequently released from HU (þHU ! release) that entered mitosis with two centrosomes also produced a bipolar mitotic division that resulted in two daughter cells, with each having one nucleus and one centrosome ( Figure 6B , second row, and Video S1). Analysis of the DNA content of these daughter cells demonstrated a similar mean fold difference of 1.09. Cells exposed to and subsequently released from HU (þHU ! release) that entered mitosis with more than two centrosomes resulted in two types of mitotic division. In the first type, the cells with more than two centrosomes produced a pseudo-bipolar mitotic division that resulted in two daughter cells, with each having one nucleus ( Figure 6B , third row, and Video S2). The cells with more than two centrosomes that divided their DNA content into two daughter cells, each with one nucleus, had a mean fold difference of 1.33. In the second type, the cells with more than two centrosomes had a multipolar mitotic division that produced two or three daughter cells, each containing one, two, or, in some cases, more than two nuclei ( Figure 6B , fourth row, and Video S3). Analysis of the DNA content between these resultant daughter cells demonstrated a mean fold difference of 2.55. The mean fold differences of the pseudo-bipolar and multipolar mitotic divisions with more than two centrosomes were statistically significant (p , 0.05) as compared to the bipolar mitotic divisions with two centrosomes ( Figure 6C , yellow bars). These data strongly support the conclusion that the generation of supernumerary centrosomes in diploid cells plays a causal role in the generation of aneuploid daughter cells.
Loss of p16 INK4a Plays a Causal Role in Centrosome Dysfunction and the Subsequent Generation of Aneuploid Daughter Cells in Multiple Cell Types
To determine if the p16
INK4a -related centrosomal dysfunction described above extends to coupled cell types other than HMECs, we suppressed expression of p16
INK4a in human mammary fibroblasts (HMFs), newborn dermal foreskin fibroblasts (NHFs), and the ''classically coupled'' HeLa cells with p16
INK4a shRNA. Western blot analysis and immunocytochemistry demonstrated that stable expression of p16 INK4a shRNA resulted in an approximately 90% suppression of p16 INK4a protein expression in both HMFs and NHFs and a 33% suppression in HeLa cells ( Figure 7A , representative data shown for HMF and HeLa cells). HU-exposed, p16
INK4a -suppressed HMFs, NHFs, and HeLa cells contained an average of 14%, 11%, and 8%, respectively, mononucleated cells with more than two centrosomes. This represented a statistically significant (p ¼ 0.02, p ¼ 0.04, p ¼ 0.01, respectively) increase in cells with more than two centrosomes compared to untreated cells (Figure 7B and 7C) . Following HU exposure, HMF, NHF, and HeLa parental (p ¼ 1.00, p ¼ 0.70, p ¼ 0.44, respectively) and vector-only control (p ¼ 0.60, p ¼ 0.27, p ¼ 1.00, respectively) populations had no statistically significant increase in cells with more than two centrosomes ( Figure 7C ). To determine if loss of p16
INK4a is causal for the supernumerary centrosome-related aneuploidy described in HMECs, we also performed the described HU exposure and release on NHFs that were infected with p16
INK4a shRNA. HU-exposed and subsequently released parental NHFs and NHFs infected with vector-only had no significant increase in the fraction of cells with more than two centrosomes and no significant increase in the number of genomic abnormalities as compared to untreated controls ( Figure 7D ). In contrast, NHFs infected with p16
INK4a shRNA that were exposed and subsequently released from HU had a significant increase (p , 0.05) in both the fraction of cells with more than two centrosomes and aneuploidy following exposure to HU compared to untreated controls ( Figure 7D ).
Loss of p16
INK4a Results in Unregulated Kinase Activity during Inhibition of DNA Replication Next, we tested the hypothesis that p16
INK4a prevents centriole pair splitting through the regulation of Cdk2 activity. vHMECs were arrested in S phase with HU for various times (0, 6, 12, 24, 36, and 48 h) to determine the timecourse of S phase arrest and to determine when cells acquire more than two centrosomes following treatment with HU ( Figure 8) . Results demonstrate that S phase arrest was achieved at 36 h ( Figure 8A ). In addition, the results reveal that vHMECs acquire more than two centrosomes at 48 h, 12 h after the cells become arrested in S phase ( Figure 8B ). To assess if Cdk2 activity is required for acquisition of more than two centrosomes, the Cdk2 inhibitor purvalanol A or roscovitine was added (10 lM) to vHMECs that had been exposed to HU for 36 h, incubated for an additional 12 h, and analyzed for the number of centrosomes per cell ( Figure 8B ). vHMECs did not acquire more than two centrosomes following HU exposure in the presence of purvalanol A and roscovitine ( Figure 8B ). Purvalanol A and roscovitine can individually inhibit more than one kinase; however, these two chemical inhibitors have overlapping specificity for Cdk2 inhibition (known to normally be active during S phase) [33] . Therefore, results demonstrating that both inhibitors prevent generation of more than two centrosomes strongly implicate a specific role for regulation of Cdk2 activity in uncoupling of the centrosome duplication and DNA replication cycles. These results suggest that p16
INK4a prevents centrosome dysfunction through regulation of Cdk2 activity.
Expression of p16 INK4a has been shown to regulate Cdk2 activity and consequently centrosome biology through both pRb (retinoblastoma)-dependent and pRb-independent mechanisms (see model, Figure 8D ). First, p16
INK4a acts through a pRb-dependent pathway via binding to Cdk4 and inhibition of the cyclin D1/Cdk4 complex. In the absence of active cyclin D1/Cdk4 complex, pRb remains associated with E2F, thereby inhibiting transcriptional activation of the Cdk2 binding partners, cyclin E and A ( Figure 8D, #1) . Alternatively, acting through a pRb-independent pathway, expression of p16
INK4a and its disruption of the association of the cyclin D1/Cdk4 complex have also been shown to directly inhibit Cdk2 activity through a second mechanism. The Cdk inhibitor p21 has been shown to be an assembly factor for the cyclin D1/Cdk4 complex. Therefore, p16 INK4a -mediated dissociation of the cyclin D1/Cdk4/p21 complex results in release of p21. When unbound p21 accumulates to a certain threshold, it binds to and inactivates the cyclin E/A-Cdk2 complex ( Figure 8D, #2) [34, 35] .
To test the proposed pRB-independent model, we used normal human diploid fibroblasts (HDFs) that have p21 inactivated through targeted homologous recombination (p21 À/À ) [36] . If p16
INK4a -dependent centrosomal dysfunction is working through this pathway, we anticipate that p21 À/À cells would phenocopy loss of p16 INK4a . Following HU exposure, an average of 22% of the HDFs (p21 À/À ) had more than two centrosomes, similar to the number generated in HDFs lacking functional p16
INK4a (NHF p16 INK4a -shRNA). In contrast, an average of 3% of the HU-exposed HDFs (p21 þ/þ ) contained more than two centrosomes ( Figure 8C ). HDFs (p21 À/À ) had a statistically significant increase in the percentage of cells with more than two centrosomes (p , 0.005) as compared to untreated controls.
Discussion
Supernumerary Centrosomes Lead to Generation of Aneuploid Daughter Cells
Theodor Boveri hypothesized over 100 years ago that multipolar mitoses were responsible for aneuploidy [6, 7] . Previous reports identifying more than two centrosomes in premalignant and malignant cancers and the correlation with aneuploidy provided support for Boveri's hypothesis [8] [9] [10] [11] . However, these correlations do not definitively demonstrate that centrosome abnormalities drive genomic instability [12] . In contrast to the majority of studies that use tissue culture cell lines, we looked at genomically intact cells with normal numbers of centrosomes, generated more than two centrosomes in these cells, and subsequently demonstrate that they accumulate multipolar mitotic spindles and an aneuploid INK4a can mediate Cdk2 activity. The p16 INK4a protein inhibits the G1 kinase activity of the cyclinD1-Cdk4 complex by binding to Cdk4 and preventing its association with cyclinD1, thereby preventing transcriptional activation of the Cdk2 binding partners cyclin E/A (Mechanism 1). The p21 kinase inhibitor is required for assembly of and stabilization of the cyclinD1-Cdk4 complex. In the presence of p16 INK4a , the cyclinD1-Cdk4 complex is disrupted, causing p21 to be released. When p21 accumulates to a critical threshold, it can bind to and inhibit the late G1 and S phase kinase activity of the cylinE/A-Cdk2 complex (Mechanism 2). DOI: 10.1371/journal.pbio.0040051.g008
karyotype. Cells with supernumerary centrosomes were shown to divide into two nuclei or more than two nuclei. Quantitation revealed that both events resulted in unequal segregation of the DNA. The fold differences observed when cells with supernumerary centrosomes divide into two nuclei likely reflect the unequal segregation of one to two chromosomes (aneuploidy), an interpretation supported by the corresponding karyotypic analysis of these cells. When the cells divide into more than one nucleus, often two or more of the nuclei remain together to form one cell, representing a mechanism for the formation of binucleated and multinucleated cells. These results strongly suggest that supernumerary centrosomes can indeed cause aneuploidy (genomic instability).
produced amphotropic retrovirus by transfecting Phoenix-A packaging cells with empty vector, GFP shRNA, and p16 INK4a shRNA using LipofectAMINE PLUS reagent (Qiagen, Valencia, California, United States) and harvesting and filtering the virus-containing culture medium 48 and 72 h posttransfection. Transfection frequency was routinely greater than 60%, as determined by parallel transfection of Phoenix-A cells with a plasmid containing a GFP expression cassette (data not shown). Cells were infected by exposing them to viruscontaining medium for 4-6 h, each with an intervening 20-h recovery period. At 72-96 h after the first infection, cells were trypsinized and plated in the presence of 4 lg/ml Puromycin (Sigma) or 20 lg/ml Hygromycin (Sigma). Following infection, cells were maintained in medium containing 4 lg/ml Puromycin and/or 20 lg/ml Hygromycin as appropriate. Infection frequencies were routinely in the range of 3% to 10%, as determined by colony formation assays.
Chromosomal analysis. Metaphase spreads were prepared from cells treated with colcemid (KaryoMAX; GIBCO-BRL, 100 ng/ml for 2 h). We performed standard G-banding karyotypic analysis on at least 50 metaphase spreads for each population described. Metaphase spreads were classified as abnormal if they contained any complement of chromosomes besides 46XX with normal banding patterns.
Time-lapse image analysis. Time-lapse microscopy was performed using a Zeiss LSM 510 confocal microscope with a plan-apochromat 363 oil objective (1.4 n.a.) . The EGFP-c-tubulin and EGFP-H2B fusion proteins were excited using a two-photon, titanium:sapphire laser (tuned to 880 nm). During image acquisition, the cells are maintained at a constant temperature of 37 8C with 5% CO 2 using a heated stage, a stage-mounted incubator, and a CO 2 regulator (Zeiss). A z-stack was acquired every 3-4 min. During image acquisition, the microscope was enclosed with a Plexiglas box custom made with a heater and fan (TX7 Wired Dome assembly; Lyon Electric Company, Chula Vista, California, United States) to maintain a temperature of 32-37 8C to minimize the thermal drift of the microsope. An objective heater (Zeiss) was also used at 37 8C to minimize thermal drift of the objective. Quantification of DNA content for each cell was determined using Velocity software (Improvision) to determination the total sum of EGFP-H2B signal (intensity) for each nucleus. The EGFP-H2B signal of daughter cells was quantified from up to ten time frames per mitotic division of those that resulted from mitotic division with two or more than two centrosomes. The fold difference between the daughter cells (signal intensity of daughter cell 1/signal intensity of daughter cell 2) was determined for each time frame. The fold differences of each time frame were than averaged to determine the average fold difference. Note that EGFP-c-tubulin signal was not always able to be separated from the EGFP-H2B signal when selecting and quantifying. To ensure that the selection of EGFP-c-tubulin signal is not contributing significantly to the determined fold differences, we determined the signal intensity of single centrosomes (EGFP-c-tubulin signal) as compared to a clearly defined nuclei (EGFP-H2B signal). The average total signal intensity of a single centrosome is less than 0.3% of the total signal intensity of a nucleus. Thus, the signal intensity from the EGFP-c-tubulin would not contribute to give a significant fold difference. Background subtraction of EGFP-H2B signal was performed in areas not containing nuclei. Only cells that were imaged completely within the x,y,z plane of the acquisition were used for quantitation. Statistical significance was determined by the two-sided t-test (95% confidence interval). 
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